Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients

This study investigated tigecycline exposure in critically ill patients from a population pharmacokinetic perspective to support rational dosing in intensive care unit (ICU) patients with acute and chronic liver impairment. A clinical dataset of 39 patients served as the basis for the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Amann, Lisa F., Alraish, Rawan, Broeker, Astrid, Kaffarnik, Magnus, Wicha, Sebastian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028393/
https://www.ncbi.nlm.nih.gov/pubmed/35453230
http://dx.doi.org/10.3390/antibiotics11040479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028393/
https://www.ncbi.nlm.nih.gov/pubmed/35453230
http://dx.doi.org/10.3390/antibiotics11040479

Ejemplares similares